Capital Fund Management (CFM)’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.65M Buy
720,526
+513,258
+248% +$2.6M 0.01% 481
2025
Q1
$1.1M Buy
207,268
+23,472
+13% +$124K ﹤0.01% 645
2024
Q4
$1.24M Buy
+183,796
New +$1.24M ﹤0.01% 652